Similar articles

• Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.

  Kwong YY, Lai WW, Lam DS. Kwong YY, et al. Am J Ophthalmol. 2004 Mar;137(3):593-4; author reply 594. doi: 10.1016/j.ajo.2003.11.052. Am J Ophthalmol. 2004. PMID: 15013906 No abstract available.
• Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.

  Williamson TH, O'Donnell A. Williamson TH, et al. Am J Ophthalmol. 2005 May;139(5):860-6. doi: 10.1016/j.ajo.2005.01.001. Am J Ophthalmol. 2005. PMID: 15860292
• Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.

  Hayashi K, Hayashi H. Hayashi K, et al. Am J Ophthalmol. 2005 Jun;139(6):972-82. doi: 10.1016/j.ajo.2004.12.087. Am J Ophthalmol. 2005. PMID: 15953425 Clinical Trial.
• Intravitreal steroids in the management of macular oedema.

  Sivaprasad S, McCluskey P, Lightman S. Sivaprasad S, et al. Acta Ophthalmol Scand. 2006 Dec;84(6):722-33. doi: 10.1111/j.1600-0420.2006.00698.x. Acta Ophthalmol Scand. 2006. PMID: 17083528 Review.
• Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.

  Jonas JB. Jonas JB. Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x. Acta Ophthalmol Scand. 2005. PMID: 16396641 Review.